Bill
HB 1425
Requiring coverage of pharmacogenomic testing for psychotropic medications.
2025-2026 Regular Session
Introduced by Liz Berry and 11 co-sponsors
HB 1425 requires Washington insurers to cover genetic testing that matches psychiatric patients to appropriate medications based on individual metabolism, aiming to improve treatment outcomes.
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.